BASELINE CHARACTERISTICS AND OUTCOMES IN PATIENTS WITH ANAEMIA IN CLINICAL STUDIES OF TOFACITINIB IN RHEUMATOID ARTHRITIS

被引：0
|
作者：
Moeller, Burkhard [1 ]
Finckh, Axel [2 ]
Alvaro-Gracia, Jose-Maria [3 ]
Scholz, Godehard [1 ]
Aletaha, Daniel [4 ]
Biondo, Francesca [5 ]
Strengholt, Sander [6 ]
Luis Rivas, Jose [7 ]
Connell, Carol A. [8 ]
Shi, Harry [9 ]
机构：
[1] Univ Hosp, Inselspital, Bern, Switzerland
[2] Univ Hosp Geneva, Geneva, Switzerland
[3] Hosp Univ La Princesa, Madrid, Spain
[4] Med Univ Vienna, Vienna, Austria
[5] Pfizer Inc, Rome, Italy
[6] Pfizer Inc, Capelle Aan Den Ijssel, Netherlands
[7] Pfizer SLU, Madrid, Spain
[8] Pfizer Inc, Groton, CT 06340 USA
[9] Pfizer Inc, Collegeville, PA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
D O I：
10.1136/annrheumdis-2019-eular.399
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0162
引用
收藏
页码：753 / 754
页数：2
相关论文
共 50 条
  • [41] Efficacy and Safety of Tofacitinib in Chinese Patients with Rheumatoid Arthritis
    Li, Zhan-Guo
    Liu, Yi
    Xu, Hu-Ji
    Chen, Zhi-Wei
    Bao, Chun-De
    Gu, Jie-Ruo
    Zhao, Dong-Bao
    An, Yuan
    Hwang, Lie-Ju
    Wang, Lisy
    Kremer, Joel
    Wu, Qi-Zhe
    CHINESE MEDICAL JOURNAL, 2018, 131 (22) : 2683 - +
  • [42] Herpes Zoster and Tofacitinib Therapy in Patients With Rheumatoid Arthritis
    Winthrop, Kevin L.
    Yamanaka, Hisashi
    Valdez, Hernan
    Mortensen, Eric
    Chew, Robert
    Krishnaswami, Sriram
    Kawabata, Thomas
    Riese, Richard
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 (10) : 2675 - 2684
  • [43] ADAPTABILITY, EFFECTIVENESS AND SAFETY OF TOFACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Rodriguez, Fernando
    Aza, Anggie
    Cabrera, Michael
    Santos-Moreno, Pedro
    Buitrago-Garcia, Diana
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 2154 - 2154
  • [44] DRUG SURVIVAL ANALYSIS OF TOFACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Karakoc, Y.
    Ercan, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1411 - 1411
  • [45] Real Life Retention of Tofacitinib in Patients with Rheumatoid Arthritis
    Croiteru, Aniela
    Lidar, Merav
    Reitblat, Tatiana
    Zisman, Devy
    Balbir-Gurman, Alexandra
    Meshiach, Tanya
    Almog, Ronit
    Elkayam, Ori
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [46] Clinical characteristics and outcomes of lung-dominant rheumatoid arthritis
    Chen, R.
    Zhao, L.
    Song, L.
    Chen, H.
    Zhang, X.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 983 - 983
  • [47] Efficacy and Safety of Tofacitinib in Chinese Patients with Rheumatoid Arthritis
    Zhan?Guo Li
    Yi Liu
    Hu?Ji Xu
    Zhi?Wei Chen
    Chun?De Bao
    Jie?Ruo Gu
    Dong?Bao Zhao
    Yuan An
    Lie?Ju Hwang
    Lisy Wang
    Joel Kremer
    Qi?Zhe Wu
    中华医学杂志英文版, 2018, 131 (22) : 2683 - 2692
  • [48] Efficacy and safety at 24 weeks of daily clinical use of tofacitinib in patients with rheumatoid arthritis
    Iwamoto, Naoki
    Tsuji, Sosuke
    Takatani, Ayuko
    Shimizu, Toshimasa
    Fukui, Shoichi
    Umeda, Masataka
    Nishino, Ayako
    Horai, Yoshiro
    Koga, Tomohiro
    Kawashiri, Shin-ya
    Aramaki, Toshiyuki
    Ichinose, Kunihiro
    Hirai, Yasuko
    Tamai, Mami
    Nakamura, Hideki
    Terada, Kaoru
    Origuchi, Tomoki
    Eguchi, Katsumi
    Ueki, Yukitaka
    Kawakami, Atsushi
    PLOS ONE, 2017, 12 (05):
  • [49] Effects of tofacitinib on the clinical features of periodontitis in patients with rheumatoid arthritis: two case reports
    Tetsuo Kobayashi
    Satoshi Ito
    Akira Murasawa
    Hajime Ishikawa
    Hiromasa Yoshie
    BMC Rheumatology, 3
  • [50] A hierarchical cluster analysis for clinical profiling of tofacitinib treatment response in patients with rheumatoid arthritis
    Janahiraman, Sivakami
    Shahril, Nor Shuhaila
    Jayaraj, Vivek Jason
    Ch'ng, Suyin
    Eow, Liu Hong
    Mageswaren, Eashwary
    Lim, Ai Lee
    Chong, Hwee Cheng
    Ong, Ping Seung
    Ismail, Asmahan Mohamed
    Rahim, Siti Mariam Ab
    Ng, Chun Ruh
    Suahilai, Dayang Masyrinartie
    Ramlan, Azwarina Hanim
    Too, Chun Lai
    Leong, Chee Onn
    CLINICAL RHEUMATOLOGY, 2024, 43 (08) : 2489 - 2501
12345